BRIEF-EMA Recommends Approval Of Vidprevtyn Beta As A Covid 19 Booster Vaccine

BRIEF-EMA Recommends Approval Of Vidprevtyn Beta As A Covid 19 Booster Vaccine

EMA: * EMA: EMA RECOMMENDS APPROVAL OF VIDPREVTYN BETA AS A COVID 19 BOOSTER VACCINE: 10/11/2022

* EMA- RECOMMENDED AUTHORISING COVID-19 VACCINE VIDPREVTYN BETA AS BOOSTER IN ADULTS PREVIOUSLY VACCINATED WITH MRNA OR ADENOVIRAL VECTOR COVID VACCINE * EMA: CHMP CONCLUDED BOOSTER DOSE OF VIDPREVTYN BETA IS EXPECTED TO BE AT LEAST AS EFFECTIVE AS COMIRNATY AT RESTORING PROTECTION AGAINST COVID-19 Source text for Eikon: Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.